Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma
Nozomi Niitsu, Masataka Okamoto, Sadao Aoki, Hirokazu Okumura, Tadashi Yoshino, Ikuo Miura, Masami Hirano
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
20
被引用数
(Scopus)